Bold Therapeutics last raised $5.5M in its Early Stage VC (Jul 2018).
- ·Watch Bold Therapeutics: the Monday email on marks, rounds and moves
Bold Therapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2018 | Early Stage VC | $5.5M | ▮ | ▮ |
Membership and data by Private Market View
Bold Therapeutics valuation
Bold Therapeutics's last known valuation is $140 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Bold Therapeutics raised?
Bold Therapeutics has raised $25 million in total; 1 of its rounds is on record. The largest on record was a $5.5 million early-stage round in Jul 2018.
Bold Therapeutics has filed 1 Form D with the SEC, most recently in Feb 2021 ($5.5 million sold to 48 investors).
How Bold Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bold Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Bold Therapeutics
- What is Bold Therapeutics worth?
- Bold Therapeutics's last known valuation is $140.0M.
- How much has Bold Therapeutics raised?
- Bold Therapeutics has raised $25.0M in total funding across 1 recorded rounds.
- When did Bold Therapeutics last raise?
- Bold Therapeutics last raised in Jul 2018 (Early Stage VC), raising $5.5M.